The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.
Home Explore CAR-T Cell Therapy Market Growth in Lymphoma, Leukemia, and Myeloma Cases | 2032 Forecast
View in Fullscreen

According to Fortune Business Insights, the global CAR-T cell therapy market was valued at USD 4.38 billion in 2023 and is projected to grow from USD 6.37 billion in 2024 to USD 16.35 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% during the forecast period. In 2023, North America dominated the market with a 68.72% share.

Like this book? You can publish your book online for free in a few minutes!
Share

Related Publications

Discover the best professional documents and content resources in AnyFlip Document Base.
Search
Published by sachi toshniwal, 2025-08-20 03:27:11

CAR-T Cell Therapy Market Growth in Lymphoma, Leukemia, and Myeloma Cases | 2032 Forecast

According to Fortune Business Insights, the global CAR-T cell therapy market was valued at USD 4.38 billion in 2023 and is projected to grow from USD 6.37 billion in 2024 to USD 16.35 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% during the forecast period. In 2023, North America dominated the market with a 68.72% share.

Keywords: CAR-T Cell Therapy Market

Click to View FlipBook Version